Distrobird — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free
Jcyte, Inc.
jcyte is a clinical-stage company focused on the application of progenitor cell-based technology in retinal diseases. the company's allogeneic product candidate, jcell, is delivered by simple intravitreal injection without the need for surgery or immune suppression. jcyte completed a phase 1/2a open-label study that evaluated 28 patients with retinitis pigmentosa. results indicate that jcell is well tolerated without immune suppression. the difference in mean change in best corrected visual acuity (12 months post-treatment compared to baseline) between treated eyes and untreated eyes was positive at all dose levels, with a suggestion of dose response at higher doses. jcyte was granted rmat designation by the fda in april 2017. an extension trial that includes dosing of the fellow eye, as well as a phase 2b masked, controlled study designed to confirm efficacy using bcva and other endpoints, are ongoing.
Frequently asked questions about Jcyte, Inc.
Let us help answer the most common questions you might have.
Where is Jcyte, Inc. located?
Jcyte, Inc.'s headquarters is located at 1000 Newport Center Drive, Suite 231, Newport Beach, California, United States, 92660
What is Jcyte, Inc.'s official website?
Jcyte, Inc.'s official website is jcyte.com
How many employees does Jcyte, Inc. have?
Jcyte, Inc. has 10 employees
What industry does Jcyte, Inc. belong to?
Jcyte, Inc. is in the industry of: Biotechnology
Distrobird — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free